Mogaton Tablet (Itopride Hydrochloride)

Adult dose

○ Adults: Administer itopride hydrochloride 50 mg orally 3 times daily before meals. Reduce the dose appropriately according to symptoms.

This medication should not be used in patients who have an allergy to this medication or its components or have experienced hypersensitivity reactions. It should not be administered to patients where stimulation of gastrointestinal motility may be harmful, such as those with gastrointestinal bleeding, mechanical obstruction, or perforation. This medication contains lactose, so patients with lactose intolerance or certain genetic metabolic disorders should not take it. Careful observation is required, as serious allergic reactions such as shock or anaphylaxis may occur during the use of this medication. As liver dysfunction or jaundice may develop, regular liver function tests should be performed, and if any abnormal symptoms appear, immediate consultation with a healthcare professional is necessary. Gastrointestinal symptoms such as nausea, diarrhea, constipation, abdominal pain, and excessive salivation may occur; therefore, symptoms should be monitored. CNS symptoms such as headaches, anxiety, sleep disturbances, and dizziness may also occur, requiring caution. Endocrine abnormalities like gynecomastia or increased prolactin levels may occur; thus, any abnormal symptoms should be reported to healthcare professionals. Regular blood tests are necessary as thrombocytopenia or leukopenia may appear on tests. It may affect kidney function, so BUN and creatinine levels should be monitored and managed. Allergic reactions such as rashes and itching may occur rarely, so the skin condition should be observed carefully. Tremors or chest and back pain and fatigue may appear during medication use, so symptoms should be monitored. If gastrointestinal symptoms do not improve, do not continue taking the medication for extended periods and consult with a healthcare professional. When taken concurrently with anticholinergics, the effect of this medication may be reduced, so precaution should be taken regarding dosing intervals. Women who are pregnant or may become pregnant should only use this medication if the benefit outweighs the risks, as its safety has not been established. This medication may be excreted in breast milk; therefore, nursing should be avoided or, if unavoidable, breastfeeding should be discontinued. Safety in children has not been sufficiently confirmed, so use should be cautious. Elderly patients may experience more adverse reactions due to declining bodily functions; thus, symptoms should be monitored closely, and doses should be adjusted as necessary. This medication should be stored out of reach of children and care should be taken not to transfer it to another container, as this may cause accidents or reduce quality.

• Shock
• anaphylactic-like symptoms
• hypotension
• dyspnea
• laryngeal edema
• urticaria
• pallor
• sweating
• hepatic dysfunction
• jaundice

This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is advisable to maintain storage temperature at room temperature between 1 degree and 30 degrees.

Appearance

White round film-coated tablet

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle, For export - 30 tablets/box [10 tablets/PTP x 3]